The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: DeepMatter partners with universities on automated precision

Thu, 17th Jun 2021 19:14

DeepMatter Group PLC - Bristol-based company focused on digitising chemistry - Chosen as partner for the University of Leeds, for the development of automated precision manufacturing in collaboration with the University of Sheffield, AstraZeneca PLC, Somaserve and Samsung Electronics Co.

DeepMatter will bring forward its cloud-based DigitalGlassware platform, and its low-footprint sensor package DeviceX.

"We are delighted to be partnering with both the key opinion leaders at the University of Leeds and University of Sheffield, as well as large pharma companies. Our DigitalGlassware platform will be used to provide a unique perspective on the data helping with both discovery and productivity gains for chemical reactions forming nanoparticles - an essential component in delivering effective mRNA vaccines," said Chief Executive Officer Mark Warne.

Current stock price: 1.80 pence

Year-to-date change: down 10%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump...

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover ta...

25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln *

25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.